• S A Walkinshaw.
• Liverpool Women's Hospital NHS Trust, Fetal Centre, Crown Street, Liverpool, UK, L8 7SS. steve.walkinshaw@lwh-tr.nwest.nhs.uk
• Cochrane Db Syst Rev. 2007 Jul 18; 1996 (4): CD000070CD000070.

BackgroundImpaired glucose metabolism in pregnancy may be associated with adverse pregnancy outcomes. Primary dietary therapy is used in the management of diabetes, including gestational diabetes.ObjectivesThe objective of this review was to assess the effects of primary dietary therapy in women identified as having gestational diabetes on fetal growth and neonatal outcomes.Search StrategyI searched the Cochrane Pregnancy and Childbirth Group trials register.Selection CriteriaRandomised trials of primary dietary therapy compared with no specific treatment in pregnant women with abnormal glucose tolerance test results.Data Collection And AnalysisTrial quality was assessed.Main ResultsFour studies involving 612 women were included. Trials were small and of variable quality. No differences were detected between primary dietary therapy and no primary dietary therapy for birthweight greater than 4000 grams (odds ratio 0.78, 95% confidence interval 0.45 to 1.35) or caesarean deliveries (odds ratio 0.97, 95% confidence interval 0.65 to 1.44).Authors' ConclusionsThere is not enough evidence to evaluate the use of primary dietary therapy for women who show impaired glucose metabolism during pregnancy.

7 keywords...

hide…